Respiratory Oscillometry for the Prediction of Bronchopulmonary Dysplasia (REACT)

Relationship Between Respiratory System Reactance Assessed by Respiratory Oscillometry and Respiratory Outcomes in Very Preterm Infants

The goal of this observational study is to learn about the correlation between respiratory system reactance, as assessed by respiratory oscillometry, and respiratory outcomes in preterm infants born before 32 weeks of gestation. The main question it aims to answer is if the reactance z-score at 7 postnatal days adds to relevant clinical factors in the prediction of bronchopulmonary dysplasia. Participants will receive respiratory oscillometry measurements at 7 ± 2 postnatal days.

Study Overview

Status

Recruiting

Study Type

Observational

Enrollment (Estimated)

150

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Wien
      • Vienna, Wien, Austria, 1090
        • Enrolling by invitation
        • Medical University of Vienna
      • Milano, Italy, 20122
        • Enrolling by invitation
        • Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
    • Monza E Brianza
      • Monza, Monza E Brianza, Italy, 20900
        • Recruiting
        • Fondazione IRCCS San Gerardo dei Tintori
        • Contact:
      • Amsterdam, Netherlands
        • Enrolling by invitation
        • Amsterdam UMC
      • Uppsala, Sweden, S-751 85
        • Enrolling by invitation
        • Uppsala University Children's Hospital
      • Basel, Switzerland, 4056
        • Enrolling by invitation
        • Universitäts-Kinderspital beider Basel

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

No

Sampling Method

Probability Sample

Study Population

Infants will be recruited from those admitted to tertiary-level neonatal intensive care units.

Description

Inclusion Criteria:

  • born before 32 weeks post-menstrual age

Exclusion Criteria:

  • congenital abnormalities
  • Inherited disorders of metabolism

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
no bronchopulmonary dysplasia
Group of patients who do not receive the diagnosis of bronchopulmonary dysplasia defined as the need for respiratory support at 36 weeks post-mentrual age
Measurement of respiratory system reactance by respiratory oscillometry
bronchopulmonary dysplasia
Group of patients developing bronchopulmonary dysplasia defined as the need for respiratory support at 36 weeks post-menstrual age.
Measurement of respiratory system reactance by respiratory oscillometry

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Respiratory system reactance (Xrs) at the clinical positive end-expiratory pressure
Time Frame: Xrs will be measured at 7 days of life
Xrs will be expressed in z-score using reference equation for very preterm infants
Xrs will be measured at 7 days of life

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Respiratory system reactance (Xrs) at the clinical positive end-expiratory pressure and ± 2 cmH2O
Time Frame: Xrs will be measured at 7 days of life
Xrs will be expressed in cmH2O*S/L
Xrs will be measured at 7 days of life

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Respiratory support mode
Time Frame: 7 postnatal days
Respiratory support mode will be coded as 0 = no respiratory support, 1 = nasal high flow therapy, 2 = nasal CPAP or nasal IPPV, 3 = invasive mechanical ventilation
7 postnatal days
Fraction of inspired oxygen
Time Frame: 7 days of life
7 days of life

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 15, 2023

Primary Completion (Estimated)

September 3, 2024

Study Completion (Estimated)

September 24, 2024

Study Registration Dates

First Submitted

July 19, 2023

First Submitted That Met QC Criteria

August 9, 2023

First Posted (Actual)

August 14, 2023

Study Record Updates

Last Update Posted (Actual)

March 6, 2024

Last Update Submitted That Met QC Criteria

March 5, 2024

Last Verified

March 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Bronchopulmonary Dysplasia

Clinical Trials on Respiratory Oscillometry

Subscribe